Early Palliative Care in Metastatic Lung Cancer in Northern France
Conditions
Lung Cancer Metastatic
Conditions: official terms
Lung Neoplasms
Conditions: Keywords
Early palliative care, Lung cancer, Quality of life
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Intervention
Name: multi disciplinary palliative care monthly consultations
Type: Other
Overall Status
Recruiting
Summary
Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer
Detailed Description
144 patients will be included; 72 per arm.

- "Standard" Control arm: patient supported by the onco-respiratory service.

- Intervention arm: patients benefit from early palliative care in addition to standard onco-pneumologic care.

The main criterion of judgment is the TOI score measured at 12 weeks.

FACTL questionnaires, HADS and PHQ-9 will be filled out before randomization , at 12 weeks and 21 weeks
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Being diagnosed with non-small cell lung cancer

- Proven histologically

- Metastatic proven imaging (MRI, CT Scanner, PET scan)

- Stage IV (any T, any N, M1)

- Diagnosed in the 8 weeks preceding the inclusion

- Supported outpatient

- Age> 18 years

- PS ≤2

- Patient able to understand the nature, purpose and methodology of the study

- signed Informed consent

Exclusion Criteria:

- Age <18 years

- Patient already supported by palliative care

- Patient with an activating EGFR mutation or EML4-ALK rearrangement

- Patient under trusteeship / guardianship
Location
University hospital Lille
Lille, France
Status: Recruiting
Contact: LICIA TOUZET, PRINCIPAL INVESTIGATOR - licia.touzet@CHRU-LILLE.FR
Start Date
October 2014
Completion Date
October 2017
Sponsors
University Hospital, Lille
Source
University Hospital, Lille
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page